Periodontal Infection and Endothelial Dysfunction
Impact of Periodontal Therapy on Endothelial Function
1 other identifier
interventional
102
1 country
2
Brief Summary
The purpose of this study is to determine the effect of periodontal therapy on endothelial function and other biomarkers of cardiovascular disease
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started May 2008
Typical duration for phase_3
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2008
CompletedFirst Submitted
Initial submission to the registry
May 19, 2008
CompletedFirst Posted
Study publicly available on registry
May 21, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2012
CompletedResults Posted
Study results publicly available
April 1, 2014
CompletedApril 17, 2014
March 1, 2014
2.8 years
May 19, 2008
November 26, 2013
March 31, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Brachial Artery Flow-mediated Dilation
All the assessments of vascular function were performed in the morning, in a temperature controlled room, with participants required to fast for at least 8 hours. Flow-mediated, endothelium dependent vasodilatation of the brachial artery (FMD) was measured using the technique described by Celermajer et al. using the guidelines reported by Coretti et al. FMD was calculated as the percentage of change in the diameter of brachial artery measured 45-60 s after cuff release in relation to the baseline measure (FMD%).
Baseline; 24 hours post periodontal therapy; 12 weeks post periodontal therapy
Secondary Outcomes (11)
High-sensitivity C-Reactive Protein
Baseline; 24 hours post periodontal therapy; 12 weeks post periodontal therapy
Total Cholesterol
Baseline; 24 hours post periodontal therapy; 12 weeks post periodontal therapy
White Blood Cell Count
Baseline; 24 hours post periodontal therapy; 12 weeks post periodontal therapy
Subgingival Microbiota
12 weeks post-periodontal therapy
LDL Cholesterol
Baseline; 24 hours post periodontal therapy; 12 weeks post periodontal therapy
- +6 more secondary outcomes
Study Arms (2)
One-Stage Full-Mouth Disinfection
EXPERIMENTALScaling and root planing, four quadrants in one session Tongue brushing with a 1% chlorhexidine gel (1 minute) Mouth rinsing with a 0.2% chlorhexidine solution for (2 minutes) Subgingival chlorhexidine (1%) irrigation in all pockets Twice daily rinsing with clorhexidine (1 minute) during fourteen days after the periodontal intervention Basic oral hygiene instructions Dental extractions will be performed at the end of patient followup (only in cases of teeth that could not be saved)
Periodontal care
ACTIVE COMPARATORBasic oral hygiene instructions Supragingival plaque removal
Interventions
* Scaling and root planing, four quadrants in one session * Tongue brushing with a 1% chlorhexidine gel (1 minute) * Mouth rinsing with a 0.2% chlorhexidine solution for (2 minutes) * Subgingival chlorhexidine (1%) irrigation in all pockets * Twice daily rinsing with clorhexidine (1 minute) during fourteen days after the periodontal intervention * Basic oral hygiene instructions * Dental extractions will be performed at the end of patient followup (only in cases of teeth that could not be saved)
* Basic oral hygiene instructions * Supragingival plaque removal
Eligibility Criteria
You may qualify if:
- Subjects must be 25 years of age or older
- Three or more periodontal pockets with a probing depth (PD) \> 5mm
- Have at least 20 natural teeth
- Provide informed consent and willingness to cooperate with the study protocol
You may not qualify if:
- History of antibiotic use in the previous three months
- Pregnant or lactating females
- Treatment with antihypertensive, antilipemic, antiarrhythmic, and other cardiovascular drugs
- Systemic diseases such as diabetes, HIV/AIDS, liver disease, chronic renal failure, tuberculosis, and autoimmune diseases
- Previous history of cardiovascular disease: Acute myocardial infarct, stable angina, unstable angina, heart failure, atrial fibrillation, atrioventricular block, peripheral vascular disease, cerebrovascular accident
- Patients who received periodontal treatment within the last 3 months
- Patients who require antibiotic prophylaxis before examination or treatment
- Patients with mental retardation and dementia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Red de Salud de Ladera E.S.E. Servicio de Odontología
Cali, Valle del Cauca Department, Colombia
Universidad del Valle, Facultad de Salud, Escuela de Odontología
Cali, Valle del Cauca Department, Colombia
Related Publications (2)
Ramirez JH, Parra B, Gutierrez S, Arce RM, Jaramillo A, Ariza Y, Contreras A. Biomarkers of cardiovascular disease are increased in untreated chronic periodontitis: a case control study. Aust Dent J. 2014 Mar;59(1):29-36. doi: 10.1111/adj.12139. Epub 2014 Feb 4.
PMID: 24495202RESULTRamirez JH, Arce RM, Contreras A. Periodontal treatment effects on endothelial function and cardiovascular disease biomarkers in subjects with chronic periodontitis: protocol for a randomized clinical trial. Trials. 2011 Feb 16;12:46. doi: 10.1186/1745-6215-12-46.
PMID: 21324167DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
1\. Patient recruitment take more time that previously expected, 2. Longer time than expected for the standardization for laboratory techniques, 3. Changes of the study personnel during patient recruitment and laboratory analysis of biological samples
Results Point of Contact
- Title
- Jorge Hernán Ramírez and Adolfo Contreras (adolfo@yahoo.com).
- Organization
- Universidad del Valle
Study Officials
- PRINCIPAL INVESTIGATOR
Adolfo Contreras, DDS, MS, PhD
Universidad del Valle
- PRINCIPAL INVESTIGATOR
Jorge H Ramirez, MD, MS
Universidad del Valle
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
May 19, 2008
First Posted
May 21, 2008
Study Start
May 1, 2008
Primary Completion
March 1, 2011
Study Completion
January 1, 2012
Last Updated
April 17, 2014
Results First Posted
April 1, 2014
Record last verified: 2014-03